Baby monitor trial aims to slash ER visits for NICU grads
NCT ID NCT06565390
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving high-risk infants an Owlet smart sock monitor after NICU discharge can reduce emergency room visits and hospital readmissions. The device tracks heart rate and oxygen levels and alerts caregivers to problems. 700 babies will be enrolled to see if remote monitoring helps keep them safer at home.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Owlet OSS 3.0 pulse oximeter (device)
What this could lead to
If it works, this could reduce emergency room visits and hospital readmissions for high-risk infants after NICU discharge, improving outcomes and lowering healthcare costs.
What could go wrong
This is a relatively early-stage trial with 700 participants, and the device may cause false alarms or caregiver anxiety. It may not significantly reduce ER visits or rehospitalizations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EMERGENCIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35249, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••